This may be highly significant especially for Asymptomatic Definite RHD with more severe echocardiographic findings, a subpopulation with a presumable worse outcome, in which the intervention would have a greater prognostic impact, not included in our model.
← all excerpts
Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-effectiveness of RHD screening in Brazil.
1
—
—